FUTURE TRENDS ON THE BIOSIMILAR UPTAKE IN THE EU5 AND THE US

被引：0
|
作者：
Lach, S. [1 ]
Sroka, A. [1 ]
Remuzat, C. [2 ]
Toumi, M. [3 ]
机构：
[1] Creativ Ceut, Krakow, Poland
[2] Creativ Ceut, Lyon, France
[3] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI55
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [1] TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5
    Lopez, N.
    Prada, M.
    Berard, I
    Schleich, W.
    Melson, C.
    VALUE IN HEALTH, 2018, 21 : S186 - S187
  • [2] THE PROMISING FUTURE OF DIGITAL HEALTH: A ROAD TO REIMBURSEMENT IN US & EU5 MARKETS?
    Sheppard, H.
    VALUE IN HEALTH, 2023, 26 (12) : S432 - S432
  • [3] PERCEPTIONS OF BIOSIMILAR MONOCLONAL ANTIBODIES AMONGST EU5 BUDGET HOLDERS
    Gardiner, R. B.
    VALUE IN HEALTH, 2015, 18 (03) : A200 - A201
  • [4] MARKET ACCESS TRENDS OF PHARMACEUTICAL PRODUCTS IN THE EU5 AND US (2009-2019)
    Mycka, J. M.
    Dellamano, R.
    Lobb, W.
    Dalal, N.
    Dellamano, L.
    Pereira, E.
    VALUE IN HEALTH, 2021, 24 : S151 - S151
  • [5] MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018-AN UPDATE
    Mycka, J.
    Lobb, W.
    Dellamano, R.
    Dalal, N.
    Dellamano, L.
    Pereira, E.
    Mora, M.
    Pollere, D.
    Papa, R.
    VALUE IN HEALTH, 2019, 22 : S300 - S300
  • [6] MARKET ACCESS TRENDS ACROSS THE EU5: 2010 TO 2015
    Dalal, N.
    Mycka, J.
    Dellamano, R.
    Lobb, W.
    Dellamano, L.
    Sagaydachnaya, O.
    Sudol, M.
    Mora, M.
    VALUE IN HEALTH, 2016, 19 (03) : A281 - A281
  • [7] INSIGHTS INTO FUTURE AUTOIMMUNE PRICING DYNAMICS IN EU5 & THE US, USING LEARNINGS FROM RHEUMATOID ARTHRITIS
    Smith, L.
    Edathodu, A.
    Ganesh, S.
    VALUE IN HEALTH, 2019, 22 : S430 - S430
  • [8] TIME TRENDS IN SEQUENCE OF DRUG LAUNCH ACROSS EU5
    Gubbels, L.
    Dekkers, R.
    Nijhuis, T.
    VALUE IN HEALTH, 2016, 19 (07) : A451 - A451
  • [9] NHL and rituximab biosimilar: How have prescribing behaviours changed in EU5 in 15 months?
    Franceschetti, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] MARKET ACCESS OF CELLULAR AND GENE THERAPY PRODUCTS IN THE US AND EU5
    Mycka, J.
    Dellamano, R.
    Lobb, W.
    Pereira, E.
    Dalal, N.
    Dellamano, L.
    Liguori, G.
    Poliakoff, K.
    VALUE IN HEALTH, 2017, 20 (05) : A18 - A18
12345